Physician profile
Murat Sor
NPI 1093780033
$749.23
in general payments reported to CMS, 2019-2025
15 companies · $489 in 2025
The $489 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $7.43 · 2022: $14.70 · 2024: $45.47 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $108.52 | 2025 | Nxstage System One |
| Medtronic, INC. | $105.17 | 2022-2025 | Hawkone |
| Medtronic Vascular, INC. | $92.78 | 2019 | |
| Bard Peripheral Vascular, INC. | $85.71 | 2025 | Venclose Maven Catheter, Covera |
| Argon Medical Devices, INC. | $69.04 | 2019 | |
| Cook Medical LLC | $65.33 | 2025 | Micropuncture |
| W. L. Gore & Associates, INC. | $55.58 | 2025 | Gore Viabahn Endoprosthesis |
| Shockwave Medical, INC | $49.01 | 2025 | |
| Becton, Dickinson and Company | $23.13 | 2024 | Fluency Endovascular Stent Graft |
| Abbott Laboratories | $22.34 | 2024 | Diamondback Peripheral |
| Mozarc Medical US LLC | $19.19 | 2025 | Palindrome |
| Covidien Lp | $18.34 | 2019 | |
| Cashflow Solutions, LLC | $14.90 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Tactile Systems Technology INC | $12.76 | 2019 | |
| Merit Medical Systems INC | $7.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murat Sor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.